Covered recipient · General Payments record
ALEXANDRA GEIGER
General Payments · PY2021–2024
$2,950.39
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $818.47 | 25 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $456.42 | 13 |
| UCB, Inc. | $151.86 | 2 |
| Janssen Biotech, Inc. | $117.36 | 2 |
| Lilly USA, LLC | $44.79 | 2 |
| E.R. Squibb & Sons, L.L.C. | $40.91 | 2 |
| Regeneron Healthcare Solutions, Inc. | $30.72 | 1 |
| LEO Pharma Inc. | $24.48 | 1 |
| Amgen Inc. | $19.54 | 1 |
| Kerecis Limited | $17.09 | 1 |
| GENZYME CORPORATION | $15.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.33 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784731 | CMS |
| ABBVIE INC. | $20.36 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784733 | CMS |
| ABBVIE INC. | $150.37 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784735 | CMS |
| ABBVIE INC. | $120.32 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784737 | CMS |
| ABBVIE INC. | $11.49 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784739 | CMS |
| ABBVIE INC. | $19.61 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784741 | CMS |
| ABBVIE INC. | $18.01 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784743 | CMS |
| ABBVIE INC. | $12.68 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784745 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784747 | CMS |
| ABBVIE INC. | $23.98 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784749 | CMS |
| ABBVIE INC. | $8.48 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784751 | CMS |
| ABBVIE INC. | $25.32 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784753 | CMS |
| ABBVIE INC. | $23.57 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103784755 | CMS |
| Amgen Inc. | $19.54 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117259049 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.74 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101356230 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.17 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101356320 | CMS |
| GENZYME CORPORATION | $15.29 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139567413 | CMS |
| Janssen Biotech, Inc. | $99.99 | 05/30/2024 | Education | Undisputed | 01/23/2026 | 1078335003 | CMS |
| Janssen Biotech, Inc. | $17.37 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078334872 | CMS |
| Kerecis Limited | $17.09 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120108153 | CMS |
| LEO Pharma Inc. | $24.48 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152630835 | CMS |
| Lilly USA, LLC | $21.25 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136021398 | CMS |
| Lilly USA, LLC | $23.54 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136021396 | CMS |
| Regeneron Healthcare Solutions, Inc. | $30.72 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114053919 | CMS |
| UCB, Inc. | $123.79 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143267403 | CMS |
| UCB, Inc. | $28.07 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143267407 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.